Menopause and hormone replacement therapy. The 2017 recommendations of the Italian Menopause Society.

Menopause and hormone replacement therapy. The 2017 recommendations of the Italian Menopause Society. Minerva Ginecol. 2017 Oct 03;: Authors: Gambacciani M, Biglia N, Cagnacci A, DI Carlo C, Caruso S, Cicinelli E, DE Leo V, Farris M, Gambera A, Guaschino S, Lanzone A, Paoletti AM, Russo N, Vicariotto F, Villa P, Volpe A Abstract In the last decade the risk benefits ratio of HRT has been reevaluated mainly in tens of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausel Hormone Therapy in 2013 and 2016 by leading global menopause societies (The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society, The International Menopause Society, The International Osteoporosis Foundation and The North American Menopause Society). The aim of these Recommendations is to provide a simple and updated reference on postmenopausal HRT. The term HRT typically includes estrogen replacement therapy (ERT) and estrogen- progestogen therapy (EPT). EPT can be sequential (Seq) when progestogen is added to ERT for 10-14 days a month, or continuous combined (CC) when progestogen is administered continuously every day along with a fixed amount of estrogen, In the everyday language, HRT includes also Tibolone and the Tissue Selective Estrogen Complex (TSEC). PMID: 28975776 [PubMed - as supplied by publisher]
Source: Minerva Ginecologica - Category: OBGYN Tags: Minerva Ginecol Source Type: research

Related Links:

You may have heard melasma referred to as “the mask of pregnancy,” because it is sometimes triggered by an increase in hormones in pregnant women. But while the condition may be common among pregnant women, you don’t have to be pregnant to experience melasma. “It’s not only associated with pregnancy, but can affect women at all stages of life,” says Dr. Shadi Kourosh, director of the Pigmentary Disorder and Multi-Ethnic Skin Clinic at Harvard-affiliated Massachusetts General Hospital. And it may last for many years. “Women who develop melasma in their teens or 20s or 30s may see it...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Health Pregnancy Skin and Hair Care Source Type: blogs
Is it considered safe for women with postmenopausal osteoporosis to take a treatment break? When is the optimal time to resume treatment?Menopause
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Acta Obstetricia et Gynecologica Scandinavica,Volume 0, Issue ja, -Not available-.
Source: Acta Obstetricia et Gynecologica Scandinavica - Category: OBGYN Authors: Source Type: research
We described palliative care as “aggressive symptom management for maximum quality of life at the present time.”The goal is to treat and remove, or reduce, symptoms that are bothering the person who is deeply forgetful. Symptoms such as pain, or problems like urinary tract infections, are handled in ways that make sense to the person living inAlzheimer ’s World.Learn More -Alzheimer ’s WorldIn the beginning of the journey, when the person is only a little forgetful, diseases and health problems are managed so that the body and mind continue to support each otherFOR MAXIMUM QUALITY OF LIFE IN THE NOW...
Source: Alzheimer's Reading Room, The - Category: Neurology Tags: alzheimers care alzheimers caregiving dementia help for caregivers end of life care family caregiving help alzheimer's help with dementia care memory care facility nursing home palliative care Source Type: blogs
Calcium levels of 700-1200 mg/day are recommended in postmenopausal women, but excessive doses could be harmful, highlights a new clinical guide from the European Menopause and Andropause Society.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
(Elsevier) Osteoporosis is common and affects 1 in 3 women. Calcium is vital for strong healthy bones and worldwide scientific societies have issued guidance about the daily requirements from childhood to old age. The European Menopause and Andropause Society (EMAS) has issued a new clinical guide with the aim of raising awareness of the importance of calcium in lowering the risk of osteoporosis.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Abstract: The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North American Menopause Society and identifies future research needs. An Advisory Panel of clinicians and researchers expert in the field of women's health and menopause was recruited by NAMS to review the 2012 Position Statement, evaluate new literature, assess the evidence, and reach consensus on recommendations, using the level of evidence to identify the strength of recommendations and the quality of the evidence. The Panel's recommendations were reviewed and a...
Source: Menopause - Category: OBGYN Tags: Position Statement Source Type: research
Authors: Golds G, Houdek D, Arnason T Abstract It is well recognized that bone loss accelerates in hypogonadal states, with female menopause being the classic example of sex hormones affecting the regulation of bone metabolism. Underrepresented is our knowledge of the clinical and metabolic consequences of overt male hypogonadism, as well as the more subtle age-related decline in testosterone on bone quality. While menopause and estrogen deficiency are well-known risk factors for osteoporosis in women, the effects of age-related testosterone decline in men on bone health are less well known. Much of our knowledge c...
Source: International Journal of Endocrinology - Category: Endocrinology Tags: Int J Endocrinol Source Type: research
The following Consensus Statement is endorsed by The International Menopause Society, The North American Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The Asia Pacific Menopause Federation, The International Osteoporosis Foundation and The Federation of Latin American Menopause Societies.
Source: Maturitas - Category: Primary Care Authors: Source Type: research
CONCLUSIONS: There is evidence to indicate an increase in bone mineral density at the femoral neck, lumbar spine and forearm after administration of bisphosphonates and at the lumbar spine and hip after zinc sulphate supplementation. The authors recommend that further long-term randomised control trials on different bisphosphonates and zinc supplementation therapies in people with beta-thalassaemia and osteoporosis are undertaken. PMID: 26964506 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Tags: Cochrane Database Syst Rev Source Type: research
More News: Cardiology | Cardiovascular | Heart | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Italy Health | Low Testosterone | Men | Menopause | OBGYN | Orthopaedics | Osteoporosis | USA Health